SEC Comment Letter 0000000000-23-006696 to Avalon GloboCare Corp. (ALBT)
Avalon GloboCare Corp.
Date: June 22, 2023 · CIK: 0001630212 · Accession: 0000000000-23-006696
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-272736
Letter
United States securities and exchange commission logo June 22, 2023 David Jin, M.D., Ph.D. Chief Executive Officer Avalon GloboCare Corp. 4400 Route 9 South, Suite 3100 Freehold, NJ 07728 Re:Avalon GloboCare Corp. Registration Statement on Form S-3 Filed June 16, 2023 File No. 333-272736 Dear David Jin: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven M. Skolnick, Esq.
Show Raw Text
United States securities and exchange commission logo
June 22, 2023
David Jin, M.D., Ph.D.
Chief Executive Officer
Avalon GloboCare Corp.
4400 Route 9 South, Suite 3100
Freehold, NJ 07728
Re:Avalon GloboCare Corp.
Registration Statement on Form S-3
Filed June 16, 2023
File No. 333-272736
Dear David Jin:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Steven M. Skolnick, Esq.